Featured Neurosciences Videos |view more
Approximately 10 million individuals in the United States suffer from essential tremor (ET), the most common movement disorder in older patients.
Stephen Bagley, MD, examines the role of immune checkpoint inhibitors in glioblastoma.
Corey Langer, MD, reveals a new perspective on non small-cell lung cancer (NSCLC) metastases in the brain.
Timothy Lucas, MD, PhD, examines laser therapy for the treatment of radionecrosis of the brain, metastases, glioma and epilepsy, and explains the current controversies identified with the modality.
Director of the Penn Brain Tumor Center Steven Brem, MD, considers the new paradigm for safe maximal (supratotal) resection of glioblastoma in light of recent advances in brain mapping and tractography.
Linda Bagley, MD, examines neuroradiological imaging as a resource for the differentiation of malignant from non-malignant neoplasms.
Goldie Kurtz, MD, reports on the radiotherapy (Gamma Knife) program at Penn Medicine, which saw a 30% growth between 2014 and 2016.
Donald M. O’Rourke, MD, reviews the application of recent advances in personalized cancer immunology to the treatment of glioblastoma.
Amy Pruitt, MD, offers a practical guide to the “day-to-day, hour-to-hour” management of brain tumor symptoms.
Kathryn Davis, MD, examines the epidemiology and pathophysiology of seizure and the current considerations for treatment, which now include a new generation of non-enzyme-inducing drugs.
Steven Brem, MD, offers a descriptive overview of the place of surgery in the therapeutic armamentarium for brain metastases.
Tara Gangadhar, MD, examines three recent clinical trials from ASCO 2017 that reported the use of targeted immunotherapy to gain durable partial or complete responses in patients with melanoma metastatic to the brain
Penn Medicine News